Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids

Osteoarthritis and Cartilage

Volumn 9, Issue 2, 2001, Pages 119-127

  Misumi, K ^a   Vilim, V ^b   Clegg, P D ^c   Thompson, C C M ^c   Carter, S D ^c  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

COMP; ELISA; Horse; MMP

Indexed keywords

ANTIGEN; GELATIN; GELATINASE; MATRIX PROTEIN; METALLOPROTEINASE; MONOCLONAL ANTIBODY; OLIGOMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE MATRIX; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HORSE; MEASUREMENT; MOLECULAR SIZE; MONITORING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; RELIABILITY; SEPSIS; SYNOVIAL FLUID; WESTERN BLOTTING;

EID: 0035095862     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.2000.0367     Document Type: Article

References (42)

1. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage
2. Cartilage oligomeric matrix protein: Isolation and characterization from human articular cartilage
3. Electron microscopy of native cartilage oligomeric matrix protein purified from the swarm rat chondrosarcoma reveals a five-armed structure
4. Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding
5. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins
6. COMP mediates chondrocyte attachment
7. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia
8. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen
9. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis
10. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: The Johnson county osteoarthritis project
11. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids
12. Production of cartilage matrix protein (COMP) by cultured human dermal and synovial fibroblasts
13. Expression of cartilage oligomeric matrix protein by human synovium
14. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes
15. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon
16. Tendon extracellular matrix contains pentameric thrombospondin-4 (TSP-4)
17. The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age, and load
18. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint
19. Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis
20. Cartilage oligomeric matrix protein: A novel marker of cartilage turnover detectable in synovial fluid and blood
21. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis
22. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degeneration
23. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage
24. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis
25. Matrix metalloproteinases 2 and 9 in equine synovial fluids
26. Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis
27. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation
28. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis
29. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors. Potential role for matrix cartilage oligomeric matrix protein fragments in arthritic synovial fluid
30. Imaging techniques in the diagnosis of equine joint disease
31. Cartilage markers in synovial fluid in symptomatic knee osteoarthritis
32. Glycosaminoglycans in horses with osteoarthritis
33. Variation of an epitope of keratan sulphate and total glycosaminoglycans in normal equine joints
34. Evaluation of the catabolic activity of cartilage by measurement of serum keratan sulphate concentration in foals
35. Concentrations of keratan sulphate in plasma and synovial fluid from clinically normal horses and horses with joint disease
36. Characterization of monoclonal antibodies recognising different fragments of cartilage oligomeric matrix protein in human body fluids
37. Protein measurement with the folin phenol reagent
38. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
39. Quantification of keratan sulphate in blood as a marker of cartilage catabolism
40. Matrix proteins: Potentials as body fluid markers od changes in the metabolism of cartilage and bone in arthritis
41. Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: Relation to development of knee or hip joint destruction
42. Serum biologic markers as predictors of disease progression in osteoarthritis of the knee